Trends in Transmission of Drug Resistance and Prevalence of Non-B Subtypes in Patients with Acute or Recent HIV-1 Infection in Barcelona in the Last 16 Years (1997-2012)

Abstract

ObjectivesTo evaluate the prevalence of transmitted drug resistance (TDR) and non-B subtypes in patients with acute/recent HIV-1 infection in Barcelona during the period 1997-2012.MethodsPatients from the “Hospital Clínic Primary HIV-1 Infection Cohort” with a genotyping test performed within 180 days of infection were included. The 2009 WHO List of Mutations for Surveillance of Transmitted HIV-1 Drug Resistance was used for estimating the prevalence of TDR and phylogenetic analysis for subtype determination.Results189 patients with acute/recent HIV-1 infection were analyzed in 4 time periods (1997-2000, n=28; 2001-4, n=42; 2005-8, n=55 and 2009-12, n=64). The proportion of patients with acute/recent HIV-1 infection with respect to the total of newly HIV-diagnosed patients in our center increased over the time and was 2.18%, 3.82%, 4.15% and 4.55% for the 4 periods, respectively (p=0.005). The global prevalence of TDR was 9%, or 17.9%, 9.5%, 3.6% and 9.4% by study period (p=0.2). The increase in the last period was driven by protease-inhibitor and nucleoside-reverse-transcriptase-inhibitor resistance mutations while non-nucleoside-reverse-transcriptase inhibitor TDR and TDR of more than one family decreased. The overall prevalence of non-B subtypes was 11.1%, or 0%, 4.8%, 9.1% and 20.3 by study period (p=0.01). B/F recombinants, B/G recombinants and subtype F emerged in the last period. We also noticed an increase in the number of immigrant patients (p=0.052). The proportion of men-who-have-sex-with-men (MSM) among patients with acute/recent HIV-1 infection increased over the time (p=0.04).ConclusionsThe overall prevalence of TDR in patients with acute/recent HIV-1 infection in Barcelona was 9%, and it has stayed relatively stable in recent years. Non-B subtypes and immigrants proportions progressively increased.

Epidemiological trends of HIV‐1 infection in blood donors from Catalonia, Spain (2005‐2014)

“…As would be expected, CRF02_AG was the most common HIV‐1 non‐B variant. However, we identified six individuals with the CRF_BF variant; and, although a cluster of nine individuals with this variant was identified previously in Spain, to our knowledge, very few cases of CRF_BF subtype have been reported in Catalonia . These data may indicate that rare recombinant forms are now being disseminated in our country.…”

“…In addition, an increasing prevalence of subtype F, which is common in Romania, Africa, and Brazil, has been described among men who had sex with men (MSM) in Galicia, a region in northwestern Spain . A recent study carried out in Hospital Clinic (Barcelona) reported that HIV‐1 non‐B subtypes have emerged in the last decade in patients with acute or recent infection and have reached a prevalence of 11.1% …”

Drug resistant HIV: Behaviors and characteristics among Los Angeles men who have sex with men with new HIV diagnosis

“…The prevalence of drug resistance of 19.5% among MSM in Los Angeles with new HIV diagnosis is relatively high compared to other reports [20] even when the analysis is restricted to those with acute/recent HIV infection (16.1%). This sample included those with new HIV diagnosis but no evidence of recent infection, therefore, some of this resistance may be acquired although there is evidence that transmitted resistance can persist for months or years in the absence of drug exposure[21, 22].…”

Detection of Broadly Neutralizing Activity within the First Months of HIV-1 Infection

“…1. The characteristics of the cohort of patients with early recent and late recent HIV infection, belonging to the acute/recent HIV infection cohort at the hospital clinic, are described elsewhere (32).…”